Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy

doi:10.4251/wjgo.v12.i2.173

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (22268)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

1508

WORD

322

HTML

16526

Figures (1-1)

528

Sum=18884

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

516

Download

676

Sum=1192

Publishing Process of This Article

Item

Count

Browse

912

Download

1280

Sum=2192

Feb 15, 2020 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (226)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Feb 15, 2020; 12(2): 173-181
Published online Feb 15, 2020. doi: 10.4251/wjgo.v12.i2.173

Open in New Tab Full Size Figure Download Figure

Figure 1 Τhe pancreatic ductal adenocarcinoma microenvironment consists of a significant hurdle for the efficient application of chemotherapy drugs or immunotherapeutic compounds. Combination treatments of chemotherapy, immunotherapy and radiation might render pancreatic ductal adenocarcinoma microenvironment more vulnerable to inhibition and promote effective treatment strategies.

Citation: Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 2020; 12(2): 173-181
URL: https://www.wjgnet.com/1948-5204/full/v12/i2/173.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i2.173